In the world of clinical research, data security is not just a priority: it is a necessity. Protecting patient data is essential for maintaining trust, ensuring compliance with regulatory standards, and safeguarding the integrity of study results. At Xolomon, we understand the critical importance of data security, and our platform is designed to provide researchers with a secure, compliant, and

We are proud to share that the TAUTEM study, which utilised Xolomon’s electronic data capture (EDC) platform, has been published in JAMA Surgery, one of the most prestigious surgical journals worldwide, with an impact factor of 15.9. Led by Dr Xavier Serra-Aracil and his team, this multicentre, randomised clinical trial explored an alternative approach to rectal cancer treatment. The study

The traditional clinical trial model—based in large hospitals, centralised study sites, and in-person visits, is evolving rapidly. The rise of Decentralised Clinical Trials (DCTs) is changing the way research is conducted, making participation more flexible, inclusive, and accessible to patients from all walks of life. What’s powering this shift? A new wave of digital tools that enable researchers to collect

As clinical trials grow increasingly complex and decentralised, one truth remains constant: patient engagement is vital to study success. However, capturing patient-reported outcomes (PROs) has long been a challenge, often relying on paper forms, third-party apps, or disconnected systems that slow down data flow and increase the risk of errors. Today, this is changing. An important shift is underway across